Cargando…
CD52 Is a Prognostic Biomarker and Associated With Tumor Microenvironment in Breast Cancer
Tumor microenvironment (TME) plays an essential role in the development and metastasis of breast cancer (BC). More studies are needed on the differences and functions of immune components and matrix components. In this study, we calculated the proportion of tumor-infiltrating immune cells (TICs) and...
Autores principales: | Wang, Jianxin, Zhang, Guangchen, Sui, Yang, Yang, Zhuowen, Chu, Yinzhu, Tang, Hailing, Guo, Binbin, Zhang, Cong, Wu, Changjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7667128/ https://www.ncbi.nlm.nih.gov/pubmed/33240323 http://dx.doi.org/10.3389/fgene.2020.578002 |
Ejemplares similares
-
Identification of Tumor Microenvironment-Related Prognostic Biomarkers in Luminal Breast Cancer
por: Wang, Yanyan, et al.
Publicado: (2020) -
Pyroptosis-Related Gene to Construct Prognostic Signature and Explore Immune Microenvironment and Immunotherapy Biomarkers in Bladder Cancer
por: Zhang, Xiangyu, et al.
Publicado: (2022) -
High Expression of CEMIP Correlates Poor Prognosis and the Tumur Microenvironment in Breast Cancer as a Promisingly Prognostic Biomarker
por: Dong, Xingxing, et al.
Publicado: (2021) -
Identification and analysis of DNA methylation-driven signatures for prognostic and immune microenvironments evaluation in hepatocellular carcinoma
por: Shen, Bingbing, et al.
Publicado: (2022) -
Prognostic risk of immune-associated signature in the microenvironment of brain gliomas
por: Tao, Yaling, et al.
Publicado: (2023)